Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

DOI: 10.4143/crt.2016.133

Keywords: Lung neoplasms, Biomarkers, Reactive oxygen species, Prognosis, Drug therapy, Platinum

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text